Multiple Choice
How does intravenous enzyme-replacement therapy for Gaucher disease reduce the organ storage of glucosylceramide?
A) The enzyme increases the destruction of glucosamine-filled macrophages.
B) The drug acts as a cofactor, increasing the activity of the mutated enzyme.
C) The drug increases production of all blood cells in the bone marrow, including white blood cells, which have not stored glucosylceramide.
D) The enzyme is absorbed through the plasma membranes of affected cells and converts the stored glucosylceramide into its constituent molecules.
Correct Answer:
Verified
Correct Answer:
Verified
Q18: Which manifestation is most common among individuals
Q19: Which health problem could be expected as
Q20: The mother of a teenager recently diagnosed
Q21: A 12-year-old boy with Marfan syndrome complains
Q22: If a man with Gaucher type 1
Q24: Which therapeutic option has been found beneficial
Q25: Couples from which ethnic group would derive
Q26: Which manifestation is a characteristic feature of
Q27: Which dietary alterations are necessary to help
Q28: A woman who is a carrier for